Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Top 10 Copper-producing Companies (Updated 2024)

7 Biggest Lithium-mining Companies

Copper Price Update: Q1 2024 in Review

A State-by-State Guide to Cannabis in Australia

Trending Press Releases

European Lithium to Acquire Leinster Lithium Project in Ireland with CRML Shares

Energy Fuels Announces Agreement for Transformational Acquisition of Base Resources, Creating a Global Leader in Critical Minerals Production with a Focus on Uranium, Rare Earth Elements and Heavy Mineral Sands

SOURCE ROCK ROYALTIES ANNOUNCES 2023 RESULTS INCLUDING RECORD ANNUAL & QUARTERLY FUNDS FROM OPERATIONS

Freegold Announces Start of 2024 Drilling Program at Golden Summit

Galan Signs Pivotal Commercial Agreement with Catamarca Government to Commercialise Lithium Chloride Concentrate

Acquisition of Bengal Mining - Highly Prospective Lithium Projects in Brazil’s Lithium Valley

More Press Releases
Trending Companies

Galan Lithium

GLN:AU

International Graphite

IG6:AU

Cardiex Limited

CDX:AU

CVD Equipment Corporation

CVV:US
More Companies
Trending Reports

Lithium Outlook for Australia

2024 Gold Outlook Report

2024 Copper Market Outlook (Australia Ed.)

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Kalytera Therapeutics

TSXV:KALY

Leading the Way in CBD Pharmaceuticals

Press Releases

Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products

Kalytera Therapeutics Announces Filing of Short Form Prospectus

Kalytera Therapeutics Announces Short Form Prospectus Offering of Units

Overview

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) is a clinical-stage biotechnology company focused on the development of next generation cannabidiol (CBD) pharmaceutical products. The company is pioneering the use of CBD in the prevention and treatment of Graft versus Host Disease (GvHD), a disorder suffered by as much as 50 percent of bone marrow transplant patients. Clinical trials have shown CBD to be potentially efficacious in suppressing the immune-response of the graft cells while simultaneously improving the patient’s ability to fight off infections, both essential for the prevention and treatment of GvHD.

Company Highlights

  • Phase 2 testing underway for the development of a CBD product for the prevention of GvHD
Get access to more exclusive Biotech Stock profiles here.
×